Veru enrolls first patients in phase 2b clinical trial of enobosarm and semaglutide combination for high quality weight loss

-- the phase 2b study planned to be conducted in 15 clinical sites in the united states -- -- topline clinical data expected in the fourth quarter calendar year 2024 --
VERU Ratings Summary
VERU Quant Ranking